Table 10.
Infection Outcomes with Use of Ertapenem
| |
Ertapenem not used (n = 191) |
Ertapenem used (n = 74) |
Absolute change |
Relative change |
|
||
|---|---|---|---|---|---|---|---|
| Endpoint |
n
|
% |
n
|
% |
% |
% |
p
|
| Patients with infection at 30 da | |||||||
| Any related infection | 46 | 24.1 | 9 | 12.2 | −11.9 | −49.5 | 0.032 |
| Any unrelated infection | 51 | 26.7 | 17 | 23.0 | −3.7 | −14.0 | 0.533 |
| Any related or unrelated infection | 77 | 40.3 | 23 | 31.1 | −9.2 | −22.9 | 0.164 |
| Patients with infection at 90 da | |||||||
|---|---|---|---|---|---|---|---|
| Any related infection | 53 | 27.8 | 11 | 14.9 | −12.9% | −46.4 | 0.028 |
| Any unrelated infection | 60 | 31.4 | 19 | 25.7 | -5.8 | −18.3 | 0.360 |
| Any related or unrelated infection | 85 | 44.5 | 25 | 33.8 | −10.7 | −24.1 | 0.112 |
a
Some patients in each group had both a related and an unrelated infection.